Company / R&D per Share
PUMA BIOTECHNOLOGY, INC. R&D per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.03
FY2025
5-year range
$1.03 / $3.31
FY2021-FY2025
Trend
-6.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has declined for 7 consecutive years, from $5.93 in FY2018 to $1.03 in FY2025.
Based on SEC 10-K filings.
1.03 in FY2025 with a 5-year CAGR of -24.6%.
Declined from $1.55 to $1.03 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -24.4%
- 5-Year CAGR
- -24.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- PUMA BIOTECHNOLOGY, INC.'s r&d per share has declined for 7 consecutive years.
- In FY2025, r&d per share decreased 6.4% year-over-year.
- Peak r&d per share was recorded in FY2018.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.03 | -6.4% |
| FY2024 | $1.10 | -29.3% |
| FY2023 | $1.55 | -34.6% |
| FY2022 | $2.37 | -28.4% |
| FY2021 | $3.31 | -21.2% |
| FY2020 | $4.21 | -22.4% |
| FY2019 | $5.42 | -8.5% |
| FY2018 | $5.93 | +4.7% |
| FY2017 | $5.66 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026